New order under MTEC prototype (MTEC-22-02-MPAI). The project title is, real-world observational study of partial resuscitative endovascular balloon occlusion of the aorta (PREBOA)-pro use and partial…
Active Awarded Last action
- Contract number
- W81XWH2290015
- Awardee
-
Medical Technology Enterprise Consortium UEI RTGVVL7F6J11
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $6,278,653
Award facts
- Contract value 100% obligated
- $6,278,653.17 Current and potential, with all options
- Completion date 79% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- Not on record
- Competition
- Competed Program Solicitation
- Pricing
- Other
- Place of performance
- Summerville, SC 29486, USA
- Primary consortia member
- Prytime Medical Devices Inc.
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $219,230 | |
| Original award | $6,059,423 |
About this award
The Defense Health Agency awarded a $6.28 million order to Medical Technology Enterprise Consortium under the MTEC-22-02-MPAI prototype vehicle on September 1, 2022, to conduct a real-world observational study of partial resuscitative endovascular balloon occlusion of the aorta (PREBOA-PRO) use and partial REBOA in hemorrhaging patients.
Place of performance is Summerville, South Carolina. The order carries an ultimate completion date of November 30, 2027. MTEC is a nonprofit medical technology accelerator that operates as a collaborative platform leveraging partnerships across industry, academia, and government to translate medical innovations into prototypes addressing military healthcare needs. The consortium has delivered prior awards spanning operational medicine, trauma care, regenerative medicine, infectious disease diagnostics, and hemorrhage control solutions.
Description
New order under MTEC prototype (MTEC-22-02-MPAI). The project title is, real-world observational study of partial resuscitative endovascular balloon occlusion of the aorta (PREBOA)-pro use and partial reboa in hemorrhaging patients.
Quick answers
Who was awarded contract W81XWH2290015?
W81XWH2290015 was awarded to Medical Technology Enterprise Consortium by Defense Health Agency (Department of Defense) on September 1, 2022.
How much is contract W81XWH2290015 worth?
The government has obligated $6,278,653 on W81XWH2290015.
Is contract W81XWH2290015 an order under another contract?
Yes. W81XWH2290015 is an other transaction order under W81XWH1590001, an other transaction IDV.
Was contract W81XWH2290015 competed?
The extent of competition for W81XWH2290015 was competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award